H2G.AX Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 31, 2025
Report Source: 2024 Annual Report
GreenHy2 Ltd. Stock Analysis H2G.AX
GreenHy2 Ltd. engages in the provision of structural mechanical piping services to mining, oil and gas sectors specializing in construction, maintenance, sustaining capital works, and shutdown services. The company is headquartered in Sydney, New South Wales. The firm delivers engineering solutions for renewable energy. The firm has specific expertise in solid state hydrogen storage for use in fuel cells and as hydrogen gas. Its activities include solid state hydrogen storage batteries supported by 100% renewable generation, and construction across the infrastructure, telecommunications, power, renewable energy, industrial and commercial sectors. Its products include GKN products and GKN HY2 Connect. Its GKN products include MINI with 425 kilowatt-hours (kWhrs) of storage, MEDI with two megawatt hours (MWhrs) of storage, and MEGA with four MWhrs of storage or 250 kilograms (kg) of hydrogen. The firm's tower systems can be stacked to achieve any size of storage required. GKN HY2 Connect, its digital platform, provides big data and artificial intelligence control and simulation, creating the modelling and predictive capacity required by customers.
Read More GreenHy2 Ltd (H2G.AX) Chart
Key Statistics of GreenHy2 Ltd (H2G.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.01Volume
204.09KP/E Ratio (TTM)
-52 Week Range
Market Cap
7.65MAvg. Volume
158.58KDividend Yield
-Financial Metrics & Statements of GreenHy2 Ltd (H2G.AX)
FAQ's for GreenHy2 Ltd (H2G.AX)
- According to Musaffa’s Shariah screening methodology, GreenHy2 Ltd (H2G.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.